The largest community of pharma leaders

HighTide Therapeutics Appoints Dr. Leigh MacConell as Chief Development Officer

SHENZHEN, China & ROCKVILLE, Md.–(BUSINESS WIRE)–HighTide Therapeutics Inc. (“HighTide”), a clinical-stage biopharmaceutical company, today announced the appointment of Leigh MacConell, Ph.D., as Chief Development Officer. Dr. MacConell has over 20 years of drug discovery and development experience. Most recently Dr. MacConell served as Senior Vice President, Clinical Development at Intercept Pharmaceuticals where she provided strategic leadership for the global clinical development of obetic
Source Read More

Recent Articles